377 FGFR protein phosphorylation as a biomarker for FGFR-targeted therapy in cholangiocarcinoma
Objectives/Goals: Cholangiocarcinoma is an aggressive cancer with a poor prognosis. Fibroblast Growth Factor Receptor 2 fusions are therapeutic targets in ~20% of cholangiocarcinoma, which restricts their benefit to only a subset of patients. We investigate reverse phase protein array, as a novel as...
Shranjeno v:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Cambridge University Press
2026-04-01
|
| Serija: | Journal of Clinical and Translational Science |
| Online dostop: | https://www.cambridge.org/core/product/identifier/S2059866126105433/type/journal_article |
| Oznake: |
Brez oznak, prvi označite!
|